Organon & Co.
Organon & Co. logo
OGN

Organon & Co. (OGN)

$27.050.71%

Market is closed
– opens on 8 PM, 12 Dec 2022
  • $

1D

1W

1M

1Y

3Y

5Y

Key Stats

$26.81
Day's Range
$27.39
$22.36
52-Week Range
$37.92
1 month return12.62%
3 month return9.96%
1 year return6.31%
5 year return25.39%

Company Information

Organon is a global healthcare company formed through a spinoff from Merck, known as MSD outside of the United States and Canada, to focus on improving the health of women throughout their lives. Here for her health, the company has a portfolio of more than 60 medicines and products across a range of therapeutic areas. Led by the reproductive health portfolio coupled with an expanding biosimilars business and stable franchise of established medicines, Organon’s products produce strong cash flows that will support investments in future growth opportunities in women’s health, including business development. In addition, Organon is pursuing opportunities to collaborate with biopharmaceutical innovators looking to commercialize their products by leveraging its scale and presence in fast growing international markets. Organon has a global footprint with significant scale and geographic reach, world-class commercial capabilities, and approximately 9,000 employees with headquarters located in Jersey City, New Jersey.
OrganizationOrganon & Co.
Employees10000
CEOMr. Kevin Ali
IndustryHealthcare

Analyst Recommendation

based on 10 analysts ratings

Buy
60%
Buy
40%
Hold
0%
Sell

Based on 10 Wall street analysts offering stock ratings for Organon & Co.(by analysts ranked 0 to 5 stars)

Analyst Forecast

What analysts predicted

Upside of 18.3%

Current

$27.05

Target

$32.0

Recommendation Trend

Based on 10 analyst

Current1M Ago3M Ago
Buy
6
7
6
Hold
4
6
6
Sell
0
0
0
Consensus
BUY
BUY
BUY

Company Financials

  • Annual
  • Quarterly

Highlights

Market Capitalization
6.8B
Book Value
$18.63
Dividend Share
1.12
Dividend Yield
4.3%
Earnings Per Share (EPS)
3.96
PE Ratio
6.78
Wall Street Target Price
32.0

Valuation

Trailing PE6.78
Forward PE5.03
Price/Book (mrq)
1.84
Enterprise Value
15.0B
Enterprise Value/Revenue
2.38
Enterprise Value/Ebitda
8.02

Technicals

50 Day MA
24.77
200 Day MA
31.2

Institutional Holdings

Vanguard Group Inc

11.88%

BlackRock Inc

6.39%

State Street Corporation

5.02%

HHG PLC

4.84%

Mawer Investment Management Ltd

4.26%

Bank of New York Mellon Corp

3.56%

Discover more

Frequently Asked Questions

What is Organon & Co. share price today?

Can Indians buy Organon & Co. shares?

How can I buy Organon & Co. shares from India?

Can Fractional shares of Organon & Co. be purchased?

What are the documents required to start investing in Organon & Co. stocks?

What are today’s High and Low prices of Organon & Co.?

What are today’s traded volumes of Organon & Co.?

What is today’s market capitalisation of Organon & Co.?

What is the 52 Week High and Low Range of Organon & Co.?

How much percentage Organon & Co. is down from its 52 Week High?

How much percentage Organon & Co. is up from its 52 Week low?

What are the historical returns of Organon & Co.?

Who is the Chief Executive Officer (CEO) of Organon & Co.?

Trading and brokerage services provided by

Banking and Remittance services provided by

Technology services provided by : Finzoomers Services Private Limited

Disclaimer: These services are not for exchange traded products.The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Finzoomers Services Private Limited acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*